The U.S. Department of Commerce Bureau of Industry and Security (“BIS”), on April 14, 2025, announced the initiation of an investigation into the imports of pharmaceuticals and pharmaceutical ingredients as well as semiconductors and semiconductor manufacturing equipment in the context of U.S. national security. This move could affect India’s USD 10 billion annual pharmaceutical exports to the U.S.
The BIS investigation would determine whether reliance on foreign pharmaceutical supply chains, particularly active pharmaceutical ingredients (“APIs”) and … Read the rest